Associate Director, Product Management – NGS Applications at Illumina

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Genomics, BiotechnologyIndustries

Requirements

Bachelor’s degree in Life Sciences, Chemistry, or related field; advanced degree (MBA, PhD) preferred
8+ years of experience in product management, preferably in life sciences or biotechnology
Deep understanding of genomics and NGS applications and ideally library preparation workflows
Proven track record of launching successful products and managing complex portfolios
Strong analytical, communication, and leadership skills
Ability to thrive in a fast-paced, matrixed environment

Responsibilities

Develop and execute the product roadmap for Library Prep solutions, aligning with company goals and market needs
Partner with R&D, marketing, sales, operations, and finance teams to bring new products to market and optimize existing offerings
Conduct market research, customer interviews, and competitive analysis to identify unmet needs and opportunities for differentiation
Oversee the full product lifecycle from concept through launch to end-of-life, ensuring sustained growth and profitability
Support go-to-market strategies, pricing models, and sales enablement tools to drive adoption and revenue
Monitor product performance metrics and customer feedback to inform continuous improvement and strategic pivots
Mentor product managers and contribute to building a high-performing product management team

Skills

Product Management

NGS

Library Preparation

Product Roadmap

Market Research

Competitive Analysis

Product Lifecycle Management

Go-to-Market Strategy

Pricing Models

Sales Enablement

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free